Lung Infection Medication Recalled Nationwide Over Possible Bacterial Contamination

Drug manufacturer Bionpharma Inc. is voluntarily recalling one of its medications used to treat serious lung infections, over possible Cohnella bacteria contamination, according to the U.S. Food and Drug Administration (FDA). The Princeton, New Jersey-headquartered company is recalling single batches of its 750 mg/mL Atovaquone Oral Suspension, a Sept. 18 FDA notice said. The affected batches of the product were manufactured by CoreRx Inc. in Clearwater, Florida, before being distributed by Bionpharma Inc. nationwide to customers between Dec. 21, 2023 and June 20, 2024. They were also distributed through wholesalers and retailers, the FDA said. According to the notice, the affected product comes in a white plastic bottle and has a lot number of 2310083, which can be found on the side panel of the bottle or the bottom flap of the carton....